PT  - JOURNAL ARTICLE
AU  - Kappanayil, Mahesh
AU  - Gurav, Aishwarya
AU  - Xavier, Sarin
AU  - Maya, Harikrishnan Anil
AU  - Srimurugan, Balaji
AU  - Sudhakar, Abish
AU  - Kumar, Raman Krishna
TI  - Immersive 3D Visualisation (3D Printing, Virtual Reality) enhances spatial understanding of complex congenital heart defects
AID  - 10.1101/2024.05.05.24306500
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.05.05.24306500
4099  - http://medrxiv.org/content/early/2024/05/26/2024.05.05.24306500.short
4100  - http://medrxiv.org/content/early/2024/05/26/2024.05.05.24306500.full
AB  - Background Diagnosing, managing complex CHD demands excellent morphological understanding. Individual differences in visuospatial skills, training and experience can impact spatial interpretation of volumetric cardiac imaging. Immersive 3D visualisation may help overcome these challenges, but evidence of clinical benefit is lacking.This study explores variability in visuospatial abilities and interpretation of conventionally viewed volumetric cardiac imaging data among members of a pediatric cardiac unit, and impact of using immersive 3D formats (3D-prints, Virtual Reality) on spatial understanding of complex CHD morphology.Methods Prospective cohort study involving 9 heterogenous members of an advanced pediatric cardiac program [3 consultant cardiologists, 2 cardiothoracic surgeons, 1 cardiac radiologist, 3 cardiology trainees]. Participants’ visuospatial abilities were quantified using a validated test (Revised PSVT:R). Understanding of spatial relationships between anatomical structures was assessed using structured questionnaires for 17 unique anonymised volumetric cardiac scans (15 CT, 2 MRI) of complex CHD visualised in three formats 1). conventional DICOM (CDICOM); 2). 3D prints (3DP); 3). Virtual Reality (VR). Accuracy, time taken, perceived level of difficulty, and confidence in interpretation were assessed and compared.Results Spatial abilities varied widely (median 8, IQR 6-30), independent of expertise/experience. Limitations in conventional reading were significantly overcome with immersive 3D. Mean accuracy score of 60.48% ±17.13% with CDICOM increased to 83.93% ± 7.84% with 3DP, and 90.81% ± 5.03% with VR (p<0.001). 3DP and VR permitted significantly faster interpretation (p<0.001), with significantly better ease and confidence. While immersive 3D visualisation led to significantly improved spatial understanding for all, it also minimised differences between participants with widely variable skill and experience levels.Conclusion This study provides evidence that immersive 3D visualisation can enhance spatial understanding of complex CHD morphology, overcoming challenges in spatial ability, experience, expertise. These technologies may be suitably leveraged as effective clinical and teaching tools in congenital cardiology.What is already known on this subject There is increasing exploration of use of novel immersive 3D technologies like 3D printing and Virtual/Augmented Reality in planning congenital cardiac surgery. Case reports and case series cite their use in visualising cardiovascular imaging data, but do not offer objective evidence or mechanistic insights on how immersive 3D interaction helps.What this study adds This study provides objective and subjective evidence that 3D printed and Virtual Reality representations of volumetric cardiovascular imaging data results in improved spatial anatomic understanding of complex cardiac defects among members of a pediatric cardiac care team. It also highlights variability in spatial intelligence and clinical experience among team members, and that immersive 3D can help overcome these challenges while interpreting cardiac imaging information.How this study might affect research, practice or policy Greater integration of immersive 3D visualisation tools in clinical practice may improve quality of care by improving physician-understanding of complex anatomical problems. It also makes a case for use of 3D printed and digital cardiac morphological specimens in training pediatric cardiac professionals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any external funding.Partially funded by Institutional research grant of Amrita Institute of Medical SciencesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee of Amrita Institute of Medical Sciences, Kochi, India gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsCHDCongenital heart diseaseCTcomputed tomographyDICOMDigital Imaging and Communication in MedicineMRImagnetic resonance imagingPSVT:RPerdue Spatial Visualisation Test - Test of Rotations